Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- SRG +1.7%, MEG +0.8% (guidance)
Other news:
- PIK +54.7% (enters into merger agreement with Nina Footwear)
- STRO +6.7% (Sutro Biopharma and Ipsen Pharma SAS (IPSEY) entered into an Exclusive License Agreement; prices an underwritten offering of 14,478,764 shares of its common stock at a price of $5.18/share)
- ROIV +5.7% (Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million)
- RIG +4.7% (contract extension worth $195 mln)
- CRON +3.4% (FL Supreme Court allowing marijuana vote on ballot, according to Orlando Sentinel)
- SIGA +2.4% (amends agreement with Meridian Medical Technologies)
- CGC +2.4% (FL Supreme Court allowing marijuana vote on ballot, according to Orlando Sentinel)
- ACB +2.3% (FL Supreme Court allowing marijuana vote on ballot, according to Orlando Sentinel)
- NOK +2% (completes sale of platform businesses to Lumine Group)
- TNDM +2% (FDA clears 510(k) application for insulin pump)
- UMH +1.9% (increases dividend)
- ANGO +1.4% (settle litigation with Becton, Dickinson and Company)
- EYPT +1.4% (Expands Scientific Advisory Board with World-Renowned Retina Specialists)
- LECO +1.3% (acquires RedViking)
- SWK +1% (completes sale to Epiroc AB)
- PSX +1% (expands commercial scale production of renewable diesel)
- SNDL +1% (SNDL and Nova Cannabis Announce Assignment of Dutch Love Stores to Nova Cannabis and Extension of Credit Facility)
- RCKT +1% (receives EMA acceptance of RP-L102 Marketing Authorization Application for the treatment of fanconi anemia)